Lone Star agrees to buy Lonza’s Capsules and Health Ingredients division
Monday, March 9, 2026 · first reported by PE Hub
Lone Star agrees to acquire Lonza's Capsules and Health Ingredients division (CHI), which comprises hard empty capsules, dosage form solutions, and health ingredients segments. Material PE transaction relevant to portfolio company operations and deal sourcing.
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on Lone Star
Everything on this firm →- Antin agrees sale of majority stake in Vicinity Energy to Harrison StreetPrivate Equity Wire +3
- CPP Investments sells A$4.5bn Australian toll road stakes to TransurbanIPE Real Assets
- Sycamore nears $9bn sale of Boots to Weston familyPrivate Equity Wire
- Eagle Point backs $450m US government-leased real estate recapitalisationIPE Real Assets
- CSC acquires 50% Watergardens mall stake from QIC for A$480mIPE Real Assets
- Diversis buys majority stake in port software provider Tideworks from Blackstone-backed CarrixPE Hub